Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
With central banks soaking up record tonnage and global mine output peaking, the developers already permitted, financed, and turning drill rigs are being repriced fast — and one of them just sent...
-
Strategic acquisition of ~11,754 hectares connect EDM’s northern and southern corridors into a unified district-scale systemConsolidated land position increases by more than 50%, from ~21,800 hectares...
-
Latin Metals receives US$250K from Daura as Phase I drilling wraps at Cerro Bayo with assays pending and Phase II planned.
-
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Dundee Corporation (TSX: DC.A) (“Dundee” or the “Corporation”) is pleased to provide an update on Westhaven Gold Corp’s (“Westhaven”) 2026 field activities...
-
(All amounts are expressed in US dollars, tabular amounts in millions, unless otherwise stated) Fortuna generates record quarterly free cash flow1 of $174.0 million and adjusted attributable net...
-
VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) -- B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) is pleased to announce its operational and financial...
-
Highlights: Produced and sold 8,527 ounces gold at an average price of US$4,872/oz for US$42M in gross project revenues Achieved commercial production at Bayan Khundii, operating at 94% of target...
-
Phase 1a interim data for ongoing CTIM-76 (CLDN6 x CD3) trial expected in June 2026 Phase 1a interim data for ongoing CT-95 (MSLN x CD3) trial expected in September 2026 Phase 1 initiation for...
-
Mink Ventures Corporation Receives New Airborne VTEM Data on Warren Ni Cu Co Project; Eight, New, High Priority Drill Targets Identified
-
Final results confirm and build on interim BIRCH results in 23 ICH patients Primary safety endpoint met with no mortality observedEncouraging efficacy signals on all clinical and biomarker endpoints...